Literature DB >> 21339011

Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer.

Seonkyu Kim1, Byung Jun Min, Myonggeun Yoon, Jinsung Kim, Dong Ho Shin, Se Byeong Lee, Sung Yong Park, Sungkoo Cho, Dae Hyun Kim.   

Abstract

PURPOSE: To compare the secondary radiation doses following intensity-modulated radiotherapy (IMRT) and proton beam therapy (PBT) in patients with lung and liver cancer. METHODS AND MATERIALS: IMRT and PBT were planned for three lung cancer and three liver cancer patients. The treatment beams were delivered to phantoms and the corresponding secondary doses during irradiation were measured at various points 20-50 cm from the beam isocenter using ion chamber and CR-39 detectors for IMRT and PBT, respectively.
RESULTS: The secondary dose per Gy (i.e., a treatment dose of 1Gy) from PBT for lung and liver cancer, measured 20-50 cm from the isocenter, ranged from 0.17 to 0.086 mGy. The secondary dose per Gy from IMRT, however, ranged between 5.8 and 1.0 mGy, indicating that PBT is associated with a smaller dose of secondary radiation than IMRT. The internal neutron dose per Gy from PBT for lung and liver cancer, 20-50 cm from the isocenter, ranged from 0.03 to 0.008 mGy.
CONCLUSIONS: The secondary dose from PBT is less than or compatible to the secondary dose from conventional IMRT. The internal neutron dose generated by the interaction between protons and body material is generally much less than the external neutron dose from the treatment head.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21339011     DOI: 10.1016/j.radonc.2011.01.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom.

Authors:  Sayyed Bijan Jia; Mohammad Hadi Hadizadeh; Ali Asghar Mowlavi; Mahdy Ebrahimi Loushab
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-01

2.  Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer.

Authors:  Dong Wook Kim; Weon Kuu Chung; Dongoh Shin; Seongeon Hong; Sung Ho Park; Sung-Yong Park; Kwangzoo Chung; Young Kyung Lim; Dongho Shin; Se Byeong Lee; Hyun-Ho Lee; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

3.  Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma.

Authors:  Dong Wook Kim; Kwangzoo Chung; Weon Kuu Chung; Sun Hyun Bae; Dong Oh Shin; Seongeon Hong; Sung Ho Park; Sung-Yong Park; Chae-Seon Hong; Young Kyung Lim; Dongho Shin; Se Byeong Lee; Hyun-ho Lee; Jiwon Sung; Myonggeun Yoon
Journal:  Radiat Oncol       Date:  2014-05-08       Impact factor: 3.481

4.  Radiation-Induced Second Cancer Risk from External Beam Photon Radiotherapy for Head and Neck Cancer: Impact on in-Field and Out-of-Field Organs

Authors:  Vasanthan Sakthivel; Ganesh Kadirampatti Mani; Sunil Mani; Raghavendiran Boopathy
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

5.  Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.

Authors:  Rami A El Shafie; Maja Czech; Kerstin A Kessel; Daniel Habermehl; Dorothea Weber; Stefan Rieken; Nina Bougatf; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2018-05-08       Impact factor: 3.481

6.  Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy.

Authors:  Dong-Jin Kang; Young-Joo Shin; Seonghoon Jeong; Jae-Yong Jung; Hakjae Lee; Boram Lee
Journal:  Radiat Oncol       Date:  2021-06-12       Impact factor: 3.481

7.  Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer.

Authors:  Jia-Yang Lu; Zhu Lin; Jing Zheng; Pei-Xian Lin; Michael Lok-Man Cheung; Bao-Tian Huang
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.